Rheumatology and Systemic Autoimmune Disease
Build practical clinical judgment in rheumatology and systemic autoimmune disease through clear visual lessons created for international nursing learners and teaching discussions.
55 presentation slides and a matching infographic.
Lesson text and sources
Read alongside the visual presentation. Expand a lesson to review its text, teaching explanation and references.
1. Rheumatology & Autoimmune Disease
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 01 / 55 RN Clarity C20 • SYSTEM Rheumatology & Autoimmune Disease Look beyond the painful joint. Independent NCLEX-RN® preparation • USA + Canada
Teaching explanation
A focused course on systemic disease, medication safety and organ-threatening changes. It covers lupus, giant cell arteritis, systemic sclerosis, vasculitis and important joint differentials. It is not a complete specialist treatment manual. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- ACR • Lupus clinical guidelines
- Locator: 2025 SLE and 2024 lupus-nephritis guidance; distinct scopes
- https://rheumatology.org/lupus-guideline
- BSR • Systemic sclerosis guideline
- Locator: 2024; organ complications and renal crisis
- https://academic.oup.com/rheumatology/article/63/11/2956/7750184
2. Systemic disease can affect several organs
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 02 / 55 RN Clarity Systemic disease can affect several organs Ask about new symptoms beyond joint pain. Compare current function with baseline. Review disease activity, treatment and possible complications.
Teaching explanation
A known diagnosis provides context but does not explain every new symptom. Infection and medication effects can coexist with autoimmune disease. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- ACR • Lupus clinical guidelines
- Locator: 2025 SLE and 2024 lupus-nephritis guidance; distinct scopes
- https://rheumatology.org/lupus-guideline
- BSR • Systemic sclerosis guideline
- Locator: 2024; organ complications and renal crisis
- https://academic.oup.com/rheumatology/article/63/11/2956/7750184
- ACR • Granulomatosis with polyangiitis
- Locator: Lung, kidney and other organ involvement
- https://rheumatology.org/patients/granulomatosis-with-polyangiitis-wegeners
3. Connect inflammation with organ function
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 03 / 55 RN Clarity Connect inflammation with organ function 01 Inflammation can involve tissues or blood vessels. 02 The affected organ may work less effectively. 03 New functional changes guide assessment and urgency. Sources: GPA • KID · Details and public links in notes
Teaching explanation
Different diseases affect different structures. This simplified chain is not a claim that all rheumatic disease follows one mechanism. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- ACR • Granulomatosis with polyangiitis
- Locator: Lung, kidney and other organ involvement
- https://rheumatology.org/patients/granulomatosis-with-polyangiitis-wegeners
- NIDDK • Lupus nephritis
- Locator: Symptoms, kidney monitoring and treatment
- https://www.niddk.nih.gov/health-information/kidney-disease/lupus-nephritis
4. Translate the clinical language
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 04 / 55 RN Clarity Translate the clinical language 01 Flare = an increase in disease activity. 02 Vasculitis = inflammation of blood vessels. 03 DMARD = a medicine intended to modify rheumatic disease activity.
Teaching explanation
A flare is a clinical interpretation, not a label to apply automatically to pain or fever. Explain unfamiliar abbreviations during handoff and teaching. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- ACR • Lupus clinical guidelines
- Locator: 2025 SLE and 2024 lupus-nephritis guidance; distinct scopes
- https://rheumatology.org/lupus-guideline
- ACR • Granulomatosis with polyangiitis
- Locator: Lung, kidney and other organ involvement
- https://rheumatology.org/patients/granulomatosis-with-polyangiitis-wegeners
- ACR • Methotrexate information
- Locator: Weekly rheumatology use; monitoring and adverse effects
- https://rheumatology.org/patients/methotrexate-rheumatrex-trexall-otrexup-rasuvo
5. Assess the disease and the treatment together
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 05 / 55 RN Clarity Assess the disease and the treatment together 01 Review recent symptoms and medicines. 02 Ask about missed doses, new products and adverse effects. 03 Report organ-function changes and infection concerns. Sources: MTX • LUP · Details and public links in notes
Teaching explanation
The team may need to distinguish active disease from infection or treatment toxicity. Do not recommend independently stopping all long-term treatment because of a nonspecific symptom. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- ACR • Methotrexate information
- Locator: Weekly rheumatology use; monitoring and adverse effects
- https://rheumatology.org/patients/methotrexate-rheumatrex-trexall-otrexup-rasuvo
- ACR • Lupus clinical guidelines
- Locator: 2025 SLE and 2024 lupus-nephritis guidance; distinct scopes
- https://rheumatology.org/lupus-guideline
6. Follow a new symptom to a clear response
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 06 / 55 RN Clarity Follow a new symptom to a clear response 01 Identify the change and relevant disease context. 02 Obtain the appropriate assessment and authorized care. 03 Reassess and confirm the follow-up plan. Sources: TEAM · Details and public links in notes
Teaching explanation
The response should match the actual concern. A routine clinic message is not enough for acute vision loss or severe deterioration. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
7. Tests support the clinical assessment
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 07 / 55 RN Clarity Tests support the clinical assessment 01 Use trends and the patient’s symptoms together. 02 Know which organ the test helps assess. 03 Clarify unexpected results and the next action. Sources: KID • JOINT · Details and public links in notes
Teaching explanation
One inflammatory marker does not establish every flare or exclude infection. Avoid turning a laboratory result into a stand-alone diagnosis. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NIDDK • Lupus nephritis
- Locator: Symptoms, kidney monitoring and treatment
- https://www.niddk.nih.gov/health-information/kidney-disease/lupus-nephritis
- EBJIS • Native-joint septic arthritis
- Locator: 2023; diagnostic recommendations, including crystals and infection
- https://jbji.copernicus.org/articles/8/29/2023/
8. Ask what the illness changes in daily life
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 08 / 55 RN Clarity Ask what the illness changes in daily life 01 Explore fatigue, mobility and daily tasks. 02 Ask about work, family and treatment barriers. 03 Build teaching around the person’s priorities. Sources: TEAM • LUP · Details and public links in notes
Teaching explanation
Symptoms may be invisible to an observer. Respect the patient’s account and avoid equating a normal appearance with normal function. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
- ACR • Lupus clinical guidelines
- Locator: 2025 SLE and 2024 lupus-nephritis guidance; distinct scopes
- https://rheumatology.org/lupus-guideline
9. Lupus can involve the kidneys
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 09 / 55 RN Clarity Lupus can involve the kidneys 01 Kidney inflammation can alter urine findings and function. 02 Swelling or blood-pressure change may occur. 03 Monitoring helps identify involvement and response. Sources: KID · Details and public links in notes
Teaching explanation
Symptoms alone do not establish lupus nephritis, and kidney disease may need laboratory assessment before obvious symptoms. The clinical team determines the investigations. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NIDDK • Lupus nephritis
- Locator: Symptoms, kidney monitoring and treatment
- https://www.niddk.nih.gov/health-information/kidney-disease/lupus-nephritis
10. Respond to a new renal pattern
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 10 / 55 RN Clarity Respond to a new renal pattern 01 Report new swelling, urine or pressure changes. 02 Support ordered urine and blood assessment. 03 Confirm the treatment and monitoring plan. Sources: KID • TEAM · Details and public links in notes
Teaching explanation
Do not wait for severe pain; kidney involvement may not be painful. The team assesses other causes as well as lupus activity. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NIDDK • Lupus nephritis
- Locator: Symptoms, kidney monitoring and treatment
- https://www.niddk.nih.gov/health-information/kidney-disease/lupus-nephritis
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
11. Skin improvement does not prove organ stability
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 11 / 55 RN Clarity Skin improvement does not prove organ stability 01 Different organs can behave differently. 02 Continue the prescribed monitoring. 03 Report new functional or laboratory changes.
Teaching explanation
Do not infer that kidney function is normal because a rash or joint pain improved. The 2025 non-renal SLE and lupus-nephritis guidelines address distinct aspects of care. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- ACR • Lupus clinical guidelines
- Locator: 2025 SLE and 2024 lupus-nephritis guidance; distinct scopes
- https://rheumatology.org/lupus-guideline
- NIDDK • Lupus nephritis
- Locator: Symptoms, kidney monitoring and treatment
- https://www.niddk.nih.gov/health-information/kidney-disease/lupus-nephritis
12. Case 1: less joint pain hides a new concern
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 12 / 55 RN Clarity Case 1: less joint pain hides a new concern FICTIONAL BEDSIDE SCENARIO 01 A person with lupus says joint pain is better. 02 New ankle swelling and foamy urine are reported. 03 A learner assumes overall disease control has improved. Sources: KID · Details and public links in notes
Teaching explanation
Fictional case. Report the new renal pattern and obtain the appropriate assessment. These symptoms raise concern but do not independently diagnose nephritis. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NIDDK • Lupus nephritis
- Locator: Symptoms, kidney monitoring and treatment
- https://www.niddk.nih.gov/health-information/kidney-disease/lupus-nephritis
13. Case 1: separate the improved and new findings
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 13 / 55 RN Clarity Case 1: separate the improved and new findings “Joint pain is better, but swelling is new.” “The patient also reports a urine change.” “These findings need kidney assessment.” Sources: TEAM · Details and public links in notes
Teaching explanation
A useful report can contain both improvement and concern. Do not compress the entire encounter into doing better. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
- NIDDK • Lupus nephritis
- Locator: Symptoms, kidney monitoring and treatment
- https://www.niddk.nih.gov/health-information/kidney-disease/lupus-nephritis
14. Case 1: confirm the kidney plan
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 14 / 55 RN Clarity Case 1: confirm the kidney plan 01 Complete the ordered assessments. 02 Review the results and symptom trend with the team. 03 Explain the follow-up and warning changes. Sources: KID • TEAM · Details and public links in notes
Teaching explanation
The learner should identify who reviews pending results and how the patient will receive the plan. A specimen collected is not the end of follow-through. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NIDDK • Lupus nephritis
- Locator: Symptoms, kidney monitoring and treatment
- https://www.niddk.nih.gov/health-information/kidney-disease/lupus-nephritis
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
15. Methotrexate scheduling needs precision
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 15 / 55 RN Clarity Methotrexate scheduling needs precision 01 Rheumatology regimens commonly use a weekly schedule. 02 Verify the indication, dose, route and day. 03 Resolve a conflicting daily instruction before administration. Sources: MTX · Details and public links in notes
Teaching explanation
This statement is limited to the rheumatology context. Methotrexate has other indications and regimens. Do not generalize the weekly schedule to every use of the drug. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- ACR • Methotrexate information
- Locator: Weekly rheumatology use; monitoring and adverse effects
- https://rheumatology.org/patients/methotrexate-rheumatrex-trexall-otrexup-rasuvo
16. Resolve a medicine discrepancy before giving it
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 16 / 55 RN Clarity Resolve a medicine discrepancy before giving it 01 Compare the order with the verified treatment history. 02 Contact the prescriber or pharmacist promptly. 03 Administer only after the safe plan is clear. Sources: MTX • TEAM · Details and public links in notes
Teaching explanation
Do not silently change an order or simply copy the old schedule. Document the clarification and ensure the current record reflects the confirmed plan. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- ACR • Methotrexate information
- Locator: Weekly rheumatology use; monitoring and adverse effects
- https://rheumatology.org/patients/methotrexate-rheumatrex-trexall-otrexup-rasuvo
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
17. Monitoring and symptoms both matter
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 17 / 55 RN Clarity Monitoring and symptoms both matter 01 Follow the prescribed laboratory monitoring. 02 Report mouth sores, illness or other concerning symptoms. 03 Check the exact advice for infections and new medicines.
Teaching explanation
Avoid a universal monitoring interval or interaction list from memory. Product, regimen and patient factors affect the plan. Reproductive counseling belongs in the individualized treatment discussion. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- ACR • Methotrexate information
- Locator: Weekly rheumatology use; monitoring and adverse effects
- https://rheumatology.org/patients/methotrexate-rheumatrex-trexall-otrexup-rasuvo
18. Case 2: weekly becomes daily at admission
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 18 / 55 RN Clarity Case 2: weekly becomes daily at admission FICTIONAL BEDSIDE SCENARIO 01 A patient takes methotrexate weekly for rheumatoid arthritis. 02 The new admission record shows daily administration. 03 A learner plans to follow the new entry without checking. Sources: MTX · Details and public links in notes
Teaching explanation
Fictional case. Pause administration and resolve the discrepancy promptly with the appropriate clinician or pharmacist. This is a medication-safety concern, not an invitation to independently rewrite the prescription. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- ACR • Methotrexate information
- Locator: Weekly rheumatology use; monitoring and adverse effects
- https://rheumatology.org/patients/methotrexate-rheumatrex-trexall-otrexup-rasuvo
19. Case 2: state the exact mismatch
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 19 / 55 RN Clarity Case 2: state the exact mismatch “The verified rheumatology schedule is weekly.” “The admission entry says daily.” “The order needs clarification before administration.” Sources: TEAM · Details and public links in notes
Teaching explanation
Provide the actual record and last-dose information when known. Do not rely on an assumed schedule without verification. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
- ACR • Methotrexate information
- Locator: Weekly rheumatology use; monitoring and adverse effects
- https://rheumatology.org/patients/methotrexate-rheumatrex-trexall-otrexup-rasuvo
20. Case 2: verify the corrected plan is shared
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 20 / 55 RN Clarity Case 2: verify the corrected plan is shared 01 Confirm the authorized regimen and next dose. 02 Update the record through the proper process. 03 Teach the patient using the verified schedule. Sources: TEAM · Details and public links in notes
Teaching explanation
The next shift and discharge record should reflect the same plan. Ask the learner how to prevent the discrepancy from reappearing during another transition. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
21. Giant cell arteritis can threaten vision
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 21 / 55 RN Clarity Giant cell arteritis can threaten vision 01 Inflammation can compromise arterial blood supply. 02 New headache, jaw symptoms or visual changes may occur. 03 Suspected sight-threatening disease needs urgent assessment. Sources: GCA • GCAG · Details and public links in notes
Teaching explanation
Do not wait for permanent visual loss. Not every headache in an older adult is GCA, but the relevant pattern warrants prompt evaluation. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- ACR • Giant cell arteritis
- Locator: Symptoms and urgency of vision protection
- https://rheumatology.org/patients/giant-cell-arteritis
- ACR/Vasculitis Foundation • GCA guideline
- Locator: 2021; diagnosis and treatment, including threatened vision
- https://acrjournals.onlinelibrary.wiley.com/doi/10.1002/acr.24632
22. Treat a new visual symptom as urgent
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 22 / 55 RN Clarity Treat a new visual symptom as urgent 01 Clarify the change and its timing. 02 Obtain urgent medical and ophthalmic assessment. 03 Support the prescribed treatment without avoidable delay. Sources: GCAG • TEAM · Details and public links in notes
Teaching explanation
The clinical team decides on treatment and diagnostic testing. Do not teach that treatment must always wait for a biopsy when vision is threatened. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- ACR/Vasculitis Foundation • GCA guideline
- Locator: 2021; diagnosis and treatment, including threatened vision
- https://acrjournals.onlinelibrary.wiley.com/doi/10.1002/acr.24632
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
23. Transient visual changes still matter
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 23 / 55 RN Clarity Transient visual changes still matter 01 A transient visual symptom still matters. 02 Report the complete episode even if vision returns. 03 Confirm the urgent assessment plan.
Teaching explanation
A symptom that resolves can still be important. The case is about preserving the history and urgency, not diagnosing the cause from a brief episode. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- ACR • Giant cell arteritis
- Locator: Symptoms and urgency of vision protection
- https://rheumatology.org/patients/giant-cell-arteritis
- ACR/Vasculitis Foundation • GCA guideline
- Locator: 2021; diagnosis and treatment, including threatened vision
- https://acrjournals.onlinelibrary.wiley.com/doi/10.1002/acr.24632
24. Case 3: the visual change has passed
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 24 / 55 RN Clarity Case 3: the visual change has passed FICTIONAL BEDSIDE SCENARIO 01 An older adult reports a new headache and jaw discomfort with chewing. 02 There was a brief episode of visual loss. 03 A learner suggests routine follow-up because sight returned. Sources: GCA · Details and public links in notes
Teaching explanation
Fictional case. Arrange urgent assessment for the concerning pattern. Other causes remain possible; do not label the episode harmless because it was transient. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- ACR • Giant cell arteritis
- Locator: Symptoms and urgency of vision protection
- https://rheumatology.org/patients/giant-cell-arteritis
25. Case 3: preserve the sight-threatening clue
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 25 / 55 RN Clarity Case 3: preserve the sight-threatening clue “There was a new episode of visual loss.” “Headache and chewing-related jaw symptoms are also present.” “Urgent assessment is needed despite improvement.” Sources: TEAM · Details and public links in notes
Teaching explanation
Give the timing and affected eye or visual field if known. Ask the patient to describe the experience rather than imposing a medical term. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
- ACR • Giant cell arteritis
- Locator: Symptoms and urgency of vision protection
- https://rheumatology.org/patients/giant-cell-arteritis
26. Case 3: confirm treatment and review
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 26 / 55 RN Clarity Case 3: confirm treatment and review 01 Follow the urgent diagnostic and treatment plan. 02 Report further visual or neurologic changes immediately. 03 Clarify ongoing monitoring and medicine instructions. Sources: GCAG • TEAM · Details and public links in notes
Teaching explanation
Do not promise that treatment will reverse established visual loss. The aim is prompt management and prevention of further harm where possible. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- ACR/Vasculitis Foundation • GCA guideline
- Locator: 2021; diagnosis and treatment, including threatened vision
- https://acrjournals.onlinelibrary.wiley.com/doi/10.1002/acr.24632
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
27. Systemic sclerosis can affect internal organs
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 27 / 55 RN Clarity Systemic sclerosis can affect internal organs 01 Vascular changes and fibrosis can involve more than skin. 02 Lung, gastrointestinal and kidney complications may occur. 03 New organ symptoms require assessment. Sources: SSC · Details and public links in notes
Teaching explanation
The 2024 BSR guideline covers systemic sclerosis, not localized morphea. Avoid treating all conditions called scleroderma as identical. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- BSR • Systemic sclerosis guideline
- Locator: 2024; organ complications and renal crisis
- https://academic.oup.com/rheumatology/article/63/11/2956/7750184
28. Recognize a possible renal-crisis pattern
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 28 / 55 RN Clarity Recognize a possible renal-crisis pattern 01 Notice new blood-pressure elevation or renal deterioration. 02 Obtain urgent clinical assessment in the disease context. 03 Follow the directed treatment and monitoring. Sources: SSC • TEAM · Details and public links in notes
Teaching explanation
Scleroderma renal crisis is generally associated with significant new hypertension, but the clinical team assesses the complete presentation. Do not prescribe a general steroid response to every autoimmune deterioration. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- BSR • Systemic sclerosis guideline
- Locator: 2024; organ complications and renal crisis
- https://academic.oup.com/rheumatology/article/63/11/2956/7750184
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
29. Treatment decisions are disease-specific
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 29 / 55 RN Clarity Treatment decisions are disease-specific 01 A drug useful in one disease may carry risk in another. 02 Review the exact diagnosis and organ concern. 03 Clarify the plan with the treating team.
Teaching explanation
Glucocorticoid exposure requires caution in systemic sclerosis because of renal-crisis risk. This does not authorize abrupt independent withdrawal of a prescribed regimen. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- BSR • Systemic sclerosis guideline
- Locator: 2024; organ complications and renal crisis
- https://academic.oup.com/rheumatology/article/63/11/2956/7750184
30. Case 4: “It is just stress” delays review
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 30 / 55 RN Clarity Case 4: “It is just stress” delays review FICTIONAL BEDSIDE SCENARIO 01 A patient with systemic sclerosis has a major new blood-pressure rise. 02 Kidney-function results have worsened. 03 A learner attributes the change to anxiety without further assessment. Sources: SSC · Details and public links in notes
Teaching explanation
Fictional case. Obtain urgent review for possible renal crisis and other causes. Anxiety does not explain away the objective organ-function change. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- BSR • Systemic sclerosis guideline
- Locator: 2024; organ complications and renal crisis
- https://academic.oup.com/rheumatology/article/63/11/2956/7750184
31. Case 4: connect the pressure and kidney trend
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 31 / 55 RN Clarity Case 4: connect the pressure and kidney trend “Blood pressure is newly much higher.” “Kidney function has also worsened.” “This needs urgent review in systemic sclerosis.” Sources: TEAM · Details and public links in notes
Teaching explanation
Report actual values and units from the clinical record when available. This fictional case avoids an invented diagnostic cutoff. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
- BSR • Systemic sclerosis guideline
- Locator: 2024; organ complications and renal crisis
- https://academic.oup.com/rheumatology/article/63/11/2956/7750184
32. Case 4: monitor the directed response
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 32 / 55 RN Clarity Case 4: monitor the directed response 01 Follow the urgent treatment and assessment plan. 02 Reassess pressure, symptoms and renal findings. 03 Communicate the response and unresolved concerns. Sources: SSC • TEAM · Details and public links in notes
Teaching explanation
The specialist team determines therapy. Do not add an unsourced blood-pressure lowering rate or medication dose to the general lesson. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- BSR • Systemic sclerosis guideline
- Locator: 2024; organ complications and renal crisis
- https://academic.oup.com/rheumatology/article/63/11/2956/7750184
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
33. Vasculitis can connect lung and kidney findings
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 33 / 55 RN Clarity Vasculitis can connect lung and kidney findings 01 Inflamed vessels can injure multiple organs. 02 GPA may involve the respiratory tract and kidneys. 03 New combined findings need timely assessment. Sources: GPA · Details and public links in notes
Teaching explanation
Different vasculitides have different patterns. Infection and other diagnoses remain possible. Do not make an autoimmune diagnosis from a symptom pair alone. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- ACR • Granulomatosis with polyangiitis
- Locator: Lung, kidney and other organ involvement
- https://rheumatology.org/patients/granulomatosis-with-polyangiitis-wegeners
34. Respond to a new multi-organ concern
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 34 / 55 RN Clarity Respond to a new multi-organ concern 01 Assess the current respiratory and overall condition. 02 Report the organ changes and medication context. 03 Obtain urgent review when symptoms indicate deterioration. Sources: GPA • TEAM · Details and public links in notes
Teaching explanation
Hemoptysis or major respiratory deterioration requires urgent assessment regardless of the eventual cause. The team determines the required testing and treatment. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- ACR • Granulomatosis with polyangiitis
- Locator: Lung, kidney and other organ involvement
- https://rheumatology.org/patients/granulomatosis-with-polyangiitis-wegeners
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
35. Do not separate related changes in the handoff
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 35 / 55 RN Clarity Do not separate related changes in the handoff 01 Combine respiratory, urine and systemic findings. 02 State when each appeared. 03 Clarify what remains unexplained.
Teaching explanation
Two separate notes can hide a clinically important pattern. A concise synthesis helps the receiving clinician see the concern. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- ACR • Granulomatosis with polyangiitis
- Locator: Lung, kidney and other organ involvement
- https://rheumatology.org/patients/granulomatosis-with-polyangiitis-wegeners
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
36. Case 5: two notes hide one serious pattern
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 36 / 55 RN Clarity Case 5: two notes hide one serious pattern FICTIONAL BEDSIDE SCENARIO 01 A patient with known vasculitis develops new breathlessness. 02 New blood is detected in urine testing. 03 The findings are documented separately without escalation. Sources: GPA · Details and public links in notes
Teaching explanation
Fictional case. Report the combined changes and obtain assessment. They do not prove a vasculitic flare, but they should not be ignored or treated as unrelated without review. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- ACR • Granulomatosis with polyangiitis
- Locator: Lung, kidney and other organ involvement
- https://rheumatology.org/patients/granulomatosis-with-polyangiitis-wegeners
37. Case 5: put the findings together
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 37 / 55 RN Clarity Case 5: put the findings together “Respiratory symptoms are new.” “Urine findings have also changed.” “The combined pattern needs clinical review.” Sources: TEAM · Details and public links in notes
Teaching explanation
Include current respiratory observations and relevant treatment. Avoid announcing a confirmed pulmonary-renal syndrome without the diagnostic assessment. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
- ACR • Granulomatosis with polyangiitis
- Locator: Lung, kidney and other organ involvement
- https://rheumatology.org/patients/granulomatosis-with-polyangiitis-wegeners
38. Case 5: follow the organ-specific response
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 38 / 55 RN Clarity Case 5: follow the organ-specific response 01 Support the ordered evaluation and treatment. 02 Reassess breathing and the relevant renal findings. 03 Confirm the specialist and monitoring plan. Sources: GPA • TEAM · Details and public links in notes
Teaching explanation
The learner should know which findings need immediate escalation and who will review pending results. A routine follow-up interval is not assumed. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- ACR • Granulomatosis with polyangiitis
- Locator: Lung, kidney and other organ involvement
- https://rheumatology.org/patients/granulomatosis-with-polyangiitis-wegeners
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
39. Worked comparison: different organ concerns
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 39 / 55 RN Clarity Worked comparison: different organ concerns Fictional patterns • assess the whole patient Context New finding Concern to assess Lupus Swelling and urine change Kidney involvement Possible GCA Transient visual loss Sight-threatening disease Systemic sclerosis Pressure and renal change Possible renal crisis A familiar diagnosis does not settle a new symptom. Sources: KID • GCA • SSC · Details and public links in notes
Teaching explanation
This table is a clinical-judgment exercise, not a diagnostic or prescribing algorithm. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NIDDK • Lupus nephritis
- Locator: Symptoms, kidney monitoring and treatment
- https://www.niddk.nih.gov/health-information/kidney-disease/lupus-nephritis
- ACR • Giant cell arteritis
- Locator: Symptoms and urgency of vision protection
- https://rheumatology.org/patients/giant-cell-arteritis
- BSR • Systemic sclerosis guideline
- Locator: 2024; organ complications and renal crisis
- https://academic.oup.com/rheumatology/article/63/11/2956/7750184
40. Explain the priority in plain language
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 40 / 55 RN Clarity Explain the priority in plain language Identify the organ that may be at risk. State the new finding and its timing. Match the urgency to the clinical pattern. Sources: TEAM · Details and public links in notes
Teaching explanation
Ask the learner to explain why less joint pain does not automatically mean the whole disease is controlled. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
41. Practice question: a schedule discrepancy
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 41 / 55 RN Clarity Practice question: a schedule discrepancy CHOOSE • EXPLAIN YOUR REASONING 01 A: Give methotrexate daily because the new entry says so. 02 B: Clarify the weekly-versus-daily mismatch before giving it. 03 C: Rewrite the prescription without contacting anyone. Sources: MTX • TEAM · Details and public links in notes
Teaching explanation
Original single-best-answer exercise, not an official NCLEX-RN® item. B is best for the verified rheumatology schedule in the case. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- ACR • Methotrexate information
- Locator: Weekly rheumatology use; monitoring and adverse effects
- https://rheumatology.org/patients/methotrexate-rheumatrex-trexall-otrexup-rasuvo
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
42. Answer: B resolves the unsafe uncertainty
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 42 / 55 RN Clarity Answer: B resolves the unsafe uncertainty 01 The recorded schedule conflicts with verified history. 02 Prompt clarification is required. 03 The confirmed plan must reach the next caregiver. Sources: TEAM • MTX · Details and public links in notes
Teaching explanation
Ask students how they would communicate and document the discrepancy. Do not let a corrected verbal statement remain disconnected from the medication record. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
- ACR • Methotrexate information
- Locator: Weekly rheumatology use; monitoring and adverse effects
- https://rheumatology.org/patients/methotrexate-rheumatrex-trexall-otrexup-rasuvo
43. A hot joint is not automatically gout
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 43 / 55 RN Clarity A hot joint is not automatically gout 01 Crystal arthritis is one possible cause. 02 Infection can coexist with crystals. 03 Acute concerning symptoms need assessment. Sources: GOUT • JOINT · Details and public links in notes
Teaching explanation
A history of gout or crystals in fluid does not exclude septic arthritis. The team decides on sampling and treatment. This is distinct from long-term urate-lowering care. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- ACR • Gout information
- Locator: Crystal arthritis, treatment and associated conditions
- https://rheumatology.org/patients/gout
- EBJIS • Native-joint septic arthritis
- Locator: 2023; diagnostic recommendations, including crystals and infection
- https://jbji.copernicus.org/articles/8/29/2023/
44. Translate the treatment goals
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 44 / 55 RN Clarity Translate the treatment goals 01 “Disease control” means reducing harmful disease activity. 02 “Monitoring” checks response and adverse effects. 03 “Flare plan” is the patient’s agreed response to change.
Teaching explanation
Explain the specific plan rather than promising a cure. Treatment goals and measurements differ among diseases and patients. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- ACR • Lupus clinical guidelines
- Locator: 2025 SLE and 2024 lupus-nephritis guidance; distinct scopes
- https://rheumatology.org/lupus-guideline
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
45. Hand over disease, treatment and change
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 45 / 55 RN Clarity Hand over disease, treatment and change 01 State the diagnosis and relevant treatment. 02 Describe what changed and what improved. 03 Confirm pending results, urgent review and follow-up. Sources: TEAM · Details and public links in notes
Teaching explanation
A good handoff preserves both uncertainty and urgency. Do not collapse the report into flare unless that assessment has been established. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
46. Make long-term care understandable
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 46 / 55 RN Clarity Make long-term care understandable 01 Explain the verified medication schedule. 02 Confirm monitoring and symptom-contact instructions. 03 Ask about barriers to follow-up and treatment. Sources: MTX • TEAM · Details and public links in notes
Teaching explanation
Use a written schedule and teach-back when helpful. The patient should know whom to contact about illness or new medicines without independently changing the regimen from a general slide. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- ACR • Methotrexate information
- Locator: Weekly rheumatology use; monitoring and adverse effects
- https://rheumatology.org/patients/methotrexate-rheumatrex-trexall-otrexup-rasuvo
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
47. Use language that respects invisible symptoms
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 47 / 55 RN Clarity Use language that respects invisible symptoms “What is different from your usual day?” “Which task is harder now?” “Let us clarify the treatment and follow-up plan.” Sources: TEAM · Details and public links in notes
Teaching explanation
Fatigue and pain are not always visible. Validate the report while assessing new symptoms and practical needs. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
48. Use a three-step systemic-disease check
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 48 / 55 RN Clarity Use a three-step systemic-disease check 01 Identify the new organ or functional change. 02 Connect it with disease, treatment and other possible causes. 03 Obtain the needed assessment and verify follow-through. Sources: TEAM · Details and public links in notes
Teaching explanation
Apply the sequence to the five cases. The goal is to avoid automatic flare labeling and missed medication discrepancies. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
49. Know the local specialty pathways
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 49 / 55 RN Clarity Know the local specialty pathways 01 Locate urgent rheumatology, eye and renal support. 02 Verify medicine monitoring and escalation procedures. 03 Use patient-specific orders and current local guidance. Sources: TEAM · Details and public links in notes
Teaching explanation
International guidelines are clinical references, not one legal nursing scope for USA and Canada. The treating team determines specialized therapy. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
50. Teacher debrief: look beyond one symptom
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 50 / 55 RN Clarity Teacher debrief: look beyond one symptom Which new organ finding changed your priority? What alternative cause still needed consideration? How did you confirm the medication or follow-up plan?
Teaching explanation
Use paired reports: one that says joint pain improved, and another that adds new swelling. Ask learners to explain how the second report changes assessment. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
51. Evidence guide: lupus and treatment
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 51 / 55 RN Clarity Evidence guide: lupus and treatment ACR • Lupus clinical guidelines NIDDK • Lupus nephritis ACR • Methotrexate information Non-renal and renal lupus guidance have distinct scopes. Confirm the exact medication regimen. Sources: LUP • KID • MTX · Details and public links in notes
Teaching explanation
The ACR source includes 2025 SLE and 2024 lupus-nephritis guidance. Public links and locators are in notes; treatment tables are not reproduced. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- ACR • Lupus clinical guidelines
- Locator: 2025 SLE and 2024 lupus-nephritis guidance; distinct scopes
- https://rheumatology.org/lupus-guideline
- NIDDK • Lupus nephritis
- Locator: Symptoms, kidney monitoring and treatment
- https://www.niddk.nih.gov/health-information/kidney-disease/lupus-nephritis
- ACR • Methotrexate information
- Locator: Weekly rheumatology use; monitoring and adverse effects
- https://rheumatology.org/patients/methotrexate-rheumatrex-trexall-otrexup-rasuvo
52. Evidence guide: organ-threatening disease
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 52 / 55 RN Clarity Evidence guide: organ-threatening disease ACR • Giant cell arteritis ACR/Vasculitis Foundation • GCA guideline BSR • Systemic sclerosis guideline ACR • Granulomatosis with polyangiitis Urgent symptoms require the appropriate clinical pathway. Sources: GCA • GCAG • SSC • GPA · Details and public links in notes
Teaching explanation
GCA guidance is dated 2021 and systemic-sclerosis guidance 2024. The deck does not relabel them as newly issued in 2026. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- ACR • Giant cell arteritis
- Locator: Symptoms and urgency of vision protection
- https://rheumatology.org/patients/giant-cell-arteritis
- ACR/Vasculitis Foundation • GCA guideline
- Locator: 2021; diagnosis and treatment, including threatened vision
- https://acrjournals.onlinelibrary.wiley.com/doi/10.1002/acr.24632
- BSR • Systemic sclerosis guideline
- Locator: 2024; organ complications and renal crisis
- https://academic.oup.com/rheumatology/article/63/11/2956/7750184
- ACR • Granulomatosis with polyangiitis
- Locator: Lung, kidney and other organ involvement
- https://rheumatology.org/patients/granulomatosis-with-polyangiitis-wegeners
53. Evidence guide: joint and communication care
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 53 / 55 RN Clarity Evidence guide: joint and communication care ACR • Gout information EBJIS • Native-joint septic arthritis AHRQ • TeamSTEPPS tools Original fictional cases and practice question. Apply current local protocols and patient-specific orders. Sources: GOUT • JOINT • TEAM · Details and public links in notes
Teaching explanation
The resource teaches recognition, communication and follow-through. It does not replace a specialist diagnostic or treatment guideline. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- ACR • Gout information
- Locator: Crystal arthritis, treatment and associated conditions
- https://rheumatology.org/patients/gout
- EBJIS • Native-joint septic arthritis
- Locator: 2023; diagnostic recommendations, including crystals and infection
- https://jbji.copernicus.org/articles/8/29/2023/
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
54. See the organ risk behind the symptom
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 54 / 55 RN Clarity See the organ risk behind the symptom Notice what is new. Clarify the disease and treatment context. Verify the response and the next step.
Teaching explanation
End with a plain-language explanation and a concise handoff. Ask learners to identify which conclusion remains unconfirmed. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
55. Look beyond the painful joint.
Slide text
RN Clarity C20 / CLINICAL SYSTEMS RN Clarity • Learning for practice 55 / 55 RN Clarity Look beyond the painful joint. Protect organs. Clarify treatment. Follow through. RN Clarity • rnclarity.com Independent preparation for the NCLEX-RN® examination. NCLEX-RN® is an NCSBN trademark. RN Clarity is independent and not endorsed by NCSBN.
Teaching explanation
NCLEX® and NCLEX-RN® are registered trademarks of NCSBN. RN Clarity is independent and is not affiliated with, sponsored by or endorsed by NCSBN. Educational preparation, not a clinical order set. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
Supports learning and orientation. Follow current local policies and scope of practice.